Dr Saeed on the Use of Pola-R-CHP in Previously Untreated DLBCL

Hayder Saeed, MD, discusses key takeaways regarding the use of polatuzumab vedotin plus R-CHP in diffuse large B-cell lymphoma.

Related Keywords

Hayder Saeed ,International Prognostic Index ,Moffitt Cancer Center ,Malignant Hematology ,Bridging The Gaps ,Hematologic Malignancies ,